Actinium-225, aka "the world's rarest drug"

10 October 2024

The global hunt is on for Actinium-225, the rare nuclear isotope that could redefine cancer care.

"Ac-225" does not occur naturally. It can, however, be produced from radium.

The trouble is, radium is also extremely rare. Production mostly took place during the Cold War, when it was used for nuclear bombs. However, only a few kilograms of the material were produced, and production was subsequently stopped altogether.

Luckily, one Western European nation had 100-200g of the stuff tucked away in a basement.

One publicly listed Western European company will now become the key beneficiary of the find. This company signed an agreement with the domestic government to use the radium for producing Ac-225.

It is not a start-up company, but a world market leader in cancer therapy. Over the past decades, it has built a nearly 50% global market share in its particular form of cancer therapy.

The stock would be cheap anyway and a buy ahead of a new growth cycle, but now the Ac-225 potential comes on top of it.

It's a mind-boggling story, even by the standards of Undervalued-Shares.com.

Not a Member yet? Sign up for a Membership - just USD 49/year.
Already a Member? Log into your account to download the report.